Cargando…
Evaluating Allosteric Perturbations in Cannabinoid Receptor 1 by In Silico Single-Point Mutation
[Image: see text] Cannabinoid receptor 1 (CB1) is a promising drug target involved in many physiological processes. Using atomistic molecular dynamics (MD) simulations, we examined the structural effect of F237L mutation on CB1, a mutation that has qualitatively similar effects to allosteric ligand...
Autores principales: | Díaz, Oscar, Renault, Pedro, Giraldo, Jesús |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2022
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9608382/ https://www.ncbi.nlm.nih.gov/pubmed/36312415 http://dx.doi.org/10.1021/acsomega.2c04980 |
Ejemplares similares
-
Dynamical Correlations Reveal Allosteric Sites in G Protein-Coupled Receptors
por: Renault, Pedro, et al.
Publicado: (2020) -
Cannabidiol binding and negative allosteric modulation at the cannabinoid type 1 receptor in the presence of delta-9-tetrahydrocannabinol: An In Silico study
por: Chung, Hery, et al.
Publicado: (2019) -
Allosteric Modulation of Cannabinoid Receptor 1—Current Challenges and Future Opportunities
por: Hryhorowicz, Szymon, et al.
Publicado: (2019) -
Structural Optimization of the Diarylurea PSNCBAM-1, an Allosteric Modulator of Cannabinoid Receptor 1
por: Dopart, Rachel, et al.
Publicado: (2019) -
PM288. Preclinical Evaluation of Neutral Cannabinoid CB1 Receptor Antagonists and Cannabinoid CB1 Receptor Negative Allosteric Modulators for Treating Drug Addiction
por: Gardner, Eliot L., et al.
Publicado: (2016)